Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.84 -0.20 (-4.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Non-Current Deffered Revenue (2025 - 2026)

Updated

Camp4 Therapeutics (CAMP) reported Non-Current Deffered Revenue of $1.5 million for Q2 2026, down 71.2% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Non-Current Deffered Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Camp4 Therapeutics posted Non-Current Deffered Revenue of $8.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Camp4 Therapeutics 209.79 Mn 209.79 Mn - 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.50 Mn
Mar 31, 2026 5.22 Mn
Dec 31, 2025 8.11 Mn
API Access

Camp4 Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CAMP&period=max&api_key=YOUR_API_KEY